Skip Navigation LinksHome > June 2012 - Volume 7 - Issue 6 > Translational Research Index
Text sizing:
A
A
A
Journal of Thoracic Oncology:
doi: 10.1097/JTO.0b013e318253da48
Submitted Abstracts

Translational Research Index

Free Access

Activin: 105P

AFP: 74P

AKT: 81O, 117P

ALK: 76O, 81O, 87PD, 99P, 106P, 149P, 176P, 251P

Androgen receptor: 187P, 188P

ATM: 84PD, 114P

BARD1: 82PD

Bcl2: 84PD

Beta tubulin III: 72P, 79O, 89PD

Beta-catenin: 92PD

BRAF: 78O, 81O

BRCA1: 72P, 79O, 82PD, 84PD

BRCA2: 72P

C6677T: 118P

CA125: 235P

CA15-3: 235P

Cancer stem cells: 104P

CCL 18: 123P

CD19: 250O

CD27: 250O

CD139: 250O

CD28: 231O

CD3z: 231O

CD4: 100P

CD79a: 250O

CD8: 100P, 231O

CEA: 69P, 132O, 134O, 183P, 235P

CHK2: 84PD, 114P

Circulating tumor cells : 85PD

CK5/6: 107P, 125P

CK7: 125P

c-MET: 78O, 81O, 87PD, 175P

cPLA2alpha: 208P

CTLA-4: 92PD

CXCL13: 250O

CXCR4: 117P

Cyclin D1: 84PD

Cyclin E: 84PD

CYFRA 21-1: 69P

CYP1A2: 68P

DNA: 81O, 83PD, 84PD, 86PD, 109P, 110P, 113P, 114P, 115P, 163O

DR70: 70P

E-cadherin: 107P, 123P

EGFR: 72P, 78O, 81O, 91PD, 93PD, 94PD, 95P, 96P, 97P, 99P, 106P, 107P, 109P, 126P, 149P, 163O, 165O, 166O, 170PD, 173PD, 177P, 178P, 179P, 180P, 181P, 182P, 183P, 184P, 185P, 191P, 194P, 199P, 207P

EML-4 ALK: 76O, 78O, 107P, 109P, 175P, 177P

EMT: 107P, 112P, 123P

EpCAM: 85PD

EPOR: 101P

ER: 72P

ERCC1: 72P, 79O, 84PD, 89PD, 174PD

FAK: 107P

FAP: 231O

FGFR: 81O, 107P

FOXP3: 100P

GNAQ: 81O

GSTM1: 67 P, 68P

GSTP1: 67P

GSTT1: 67P, 68P

H2AX: 115P

HE4: 120P

HER2: 72P, 81O, 83PD, 165O

HER4: 165O, 166O

HEY1: 102P

HEY2: 102P

HIF-1alpha: 88PD

HRAS: 81O

HSP27: 141PD

HSP70: 141PD

HSP90: 196P, 251P

ID1: 86PD, 87PD

IRF4: 250O

Jak/Stat: 99P

KAP1: 114P

Ki67: 72P, 90PD, 92PD, 105P

KIT: 81O

KRAS: 72P, 78O, 81O, 99P, 106P, 107P, 109P, 163O, 164O, 165O, 179P, 182P, 197P

LKB1: 107P

MAP2K: 81O

MAPK: 117P

Maspin: 103P

MDR1: 68P

miR-29b: 86PD

miR-34c: 65O

miRNA: 65O, 87PD, 88PD, 115P, 174PD, 230O

MTHFR: 118P

mTOR: 107P, 211P

NAT2: 68P

NER: 84PD

Notch1: 81O, 102P

p53: 79O, 81O, 84PD, 114P, 121P, 122P

p63: 107P, 125P

p-6SK3: 99P

PAI-2: 111P

pAKT: 99P

PARP: 114P

PDGFRA: 81O

pERK1/2: 99P

pERp1: 250O

PF4: 108P

PgR: 72P

pHSP27: 141PD

PI3K/Akt: 99P

PIK3CA: 78O, 81O

Pim-2: 250O

PINP: 69P

p-mTOR: 99P

POU2AF1: 250O

p-S6K: 99P

PTEN: 78O, 81O

Pyrrolidine-2: 208P

Raf/MEK/ERK: 233P

Ras/Raf/ERK: 99P

RET: 81O

REV: 115P

RNA: 109P, 115P, 250O

RRM1: 72P, 79O, 84PD

RRM2: 79O

S100A4: 123P

SDF-1: 117P

siRNA: 102P, 105P

SIRT1: 102P

SLAM7F: 250O

Smad2: 105P

SNAIL: 107P, 123P

Src: 87PD

STAT3: 99P

STK11: 81O

TRNFRSF17: 250O

TRAP5b: 69P

TS: 72P, 79O, 113P

TTF-1: 99P, 107P, 125P, 217P

u-PA: 111P

u-PAR: 111P

VEGF: 84PD, 197P, 233P

VEGFR: 233P

VHL: 81O

WAP: 120P

WFDC2: 120P

ZEB2: 83P

© 2012International Association for the Study of Lung Cancer

Login

Article Tools

Share

Other Ways to Connect

Twitter
twitter.com/JTOonline

 



Visit JTO.org on your smartphone. Scan this code (QR reader app required) with your phone and be taken directly to the site.

 For additional oncology content, visit LWW Oncology Journals on Facebook.